Skip to main content
. 2022 Mar 29;40(19):2696–2704. doi: 10.1016/j.vaccine.2022.03.058

Table 3.

Factors Associated with Influenza Vaccination.

Odds Ratio (95% CI)a
Factor 2019–2021 2019–2020 2020–21
COVID-19 pandemic
 No 1 [Reference]
 Yes 1.23 (1.23–1.24)
Demographic characteristics
 Sex
  Male 1 [Reference] 1 [Reference] 1 [Reference]
  Female 1.14 (1.14–1.15) 1.16 (1.15–1.16) 1.13 (1.12–1.13)
 Race
  White 1 [Reference] 1 [Reference] 1 [Reference]
  Asian 1.07 (1.06–1.07) 0.96 (0.95–0.97) 1.17 (1.16–1.18)
  Black 0.92 (0.92–0.93) 0.90 (0.90–0.91) 0.94 (0.93–0.95)
  Hispanic 0.86 (0.86–0.87) 0.80 (0.79–0.80) 0.93 (0.92–0.93)
 Age in 2018
  18–24 1 [Reference] 1 [Reference] 1 [Reference]
  25–34 1.35 (1.33–1.36) 1.42 (1.40–1.44) 1.29 (1.28–1.31)
  35–44 1.50 (1.49–1.52) 1.46 (1.44–1.48) 1.55 (1.53–1.57)
  45–54 1.76 (1.75–1.78) 1.63 (1.61–1.65) 1.89 (1.87–1.91)
  55–64 2.50 (2.48–2.52) 2.35 (2.32–2.38) 2.65 (2.62–2.69)
  ≥65 3.22 (3.19–3.24) 3.19 (3.16–3.23) 3.24 (3.20–3.27)
 Income
  $100 K+ 1 [Reference] 1 [Reference] 1 [Reference]
  $75–$99 K 0.92 (0.91–0.92) 0.94 (0.93–0.95) 0.90 (0.89–0.90)
  $60–$74 K 0.88 (0.87–0.88) 0.90 (0.89–0.91) 0.86 (0.85–0.86)
  $50–$59 K 0.84 (0.84–0.85) 0.87 (0.86–0.88) 0.82 (0.81–0.83)
  $40–$49 K 0.81 (0.80–0.81) 0.84 (0.83–0.85) 0.78 (0.77–0.79)
  <$40 K 0.78 (0.78–0.78) 0.82 (0.82–0.83) 0.74 (0.74–0.75)
 Education
  Bachelor Degree Plus 1 [Reference] 1 [Reference] 1 [Reference]
  Less than Bachelor Degree 0.80 (0.80–0.80) 0.87 (0.86–0.87) 0.75 (0.74–0.75)
  High school diploma 0.75 (0.75–0.76) 0.85 (0.85–0.86) 0.67 (0.67–0.68)
  Less than 12th grade 0.71 (0.69–0.73) 0.80 (0.78–0.83) 0.64 (0.62–0.66)
Medical history
 Diagnosed with influenza last flu season
  No 1 [Reference] 1 [Reference] 1 [Reference]
  Yes 1.52 (1.50–1.54) 1.66 (1.63–1.70) 1.40 (1.38–1.43)
 Received influenza vaccine last flu season
  No 1 [Reference] 1 [Reference] 1 [Reference]
  Yes 18.56 (18.50–18.62) 21.65 (21.55–21.75) 16.08 (16.01–16.15)

Abbreviation: CI = confidence interval.

a

Multivariable analysis adjusted for demographic characteristics and medical histories. Specifications are presented in Appendix C.